These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33293807)

  • 1. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
    Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
    Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Study on Thymoquinone Conjugated ZnO Nanoparticles Mediated Cytotoxicity and Anticancer Activity in Triple-Negative Breast Cancer Cells.
    Banupriya SK; Kavithaa K; Poornima A; Sumathi S
    Anticancer Agents Med Chem; 2022; 22(2):313-327. PubMed ID: 33845751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Mitoxantrone-Loaded Quercetin Nanoparticles for Breast Cancer Therapy with Potential for Synergism with Bioactive Natural Products.
    Alkhaldi O; Abusulieh S; Abusara OH; Sunoqrot S
    Int J Pharm; 2024 Nov; 665():124674. PubMed ID: 39245083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells.
    Ahmad R; Kaus NHM; Hamid S
    Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles.
    Noor NS; Kaus NHM; Szewczuk MR; Hamid SBS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa).
    Ng WK; Saiful Yazan L; Yap LH; Wan Nor Hafiza WA; How CW; Abdullah R
    Biomed Res Int; 2015; 2015():263131. PubMed ID: 25632388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a.
    Bhattacharya S; Ahir M; Patra P; Mukherjee S; Ghosh S; Mazumdar M; Chattopadhyay S; Das T; Chattopadhyay D; Adhikary A
    Biomaterials; 2015 May; 51():91-107. PubMed ID: 25771001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Adeli-Sardou M
    Sci Rep; 2019 May; 9(1):7139. PubMed ID: 31073144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer.
    Odeh F; Ismail SI; Abu-Dahab R; Mahmoud IS; Al Bawab A
    Drug Deliv; 2012 Nov; 19(8):371-7. PubMed ID: 23043626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management.
    Zewail M; E Gaafar PM; Ali MM; Abbas H
    Drug Deliv; 2022 Dec; 29(1):1663-1674. PubMed ID: 35616281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative approach against cancer: Thymoquinone-loaded PHEMA-based magnetic nanoparticles and their effects on MCF-7 breast cancer.
    Yıldırım M; Acet Ö; Önal Acet B; Karakoç V; Odabaşı M
    Biochem Biophys Res Commun; 2024 Nov; 734():150464. PubMed ID: 39083970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
    Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
    Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells.
    Ibrahim WN; Muizzuddin Bin Mohd Rosli L; Doolaanea AA
    Int J Nanomedicine; 2020; 15():8059-8074. PubMed ID: 33116518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines.
    Goel S; Mishra P
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109881. PubMed ID: 31499940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles.
    Ganea GM; Fakayode SO; Losso JN; van Nostrum CF; Sabliov CM; Warner IM
    Nanotechnology; 2010 Jul; 21(28):285104. PubMed ID: 20585163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
    Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
    Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
    Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
    Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and biological evaluation of protective effect of kidney targeted N-acetylated chitosan nanoparticles containing thymoquinone for the treatment of DNA damage in cyclophosphamide-induced haemorrhagic cystitis.
    Prajapati C; Agrawal YO; Agnihotri VV; Mahajan UB; Patil KR; Patil DD; Patil CR
    Int J Biol Macromol; 2022 Aug; 214():391-401. PubMed ID: 35714868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.